Impaired learning and memory in Pitx3 deficient aphakia mice:: A genetic model for striatum-dependent cognitive symptoms in Parkinson's disease

被引:42
作者
Ardayfio, Paul [1 ,2 ]
Moon, JiSook [1 ]
Leung, Ka Ka Amanda [1 ]
Youn-Hwang, Dong [3 ]
Kim, Kwang-Soo [1 ,2 ]
机构
[1] Harvard Univ, Sch Med, Mol Neurobiol Lab, MRC 215McLean Hosp, Belmont, MA 02478 USA
[2] Harvard Univ, Sch Med, Program Neurosci, Cambridge, MA 02138 USA
[3] Pochon CHA Univ, Coll Med, CHA Stem Cell Inst, Seoul 135081, South Korea
关键词
cognition; Parkinson's disease; Pitx3; dopamine; striatum;
D O I
10.1016/j.nbd.2008.05.017
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Disorders of the basal ganglia such as Parkinson's disease (PD) and Huntington's disease are commonly thought of primarily as motor disorders: however, the cognitive symptoms of these diseases such as executive dysfunction, learning, memory and attention deficits are prominent and often more disabling than the hallmark motor symptoms. Cognitive features of PD are often neglected in preclinical studies of PD, likely due to the lack of available animal models to study them. Aphakia mice, which are deficient in the transcription factor Pitx3, model the selective nigrostriatal DA loss in PD. Here we report that aphakia mice are impaired in striatum-dependent cognitive tasks including rotarod learning, T-maze and inhibitory avoidance tasks, but not the striatum-independent social transmission of food preference task. These results suggest that some neuropsychiatric symptoms in PD are related to the pathophysiology of the disease rather than stress associated with disease burden, or medications used to treat PD. Furthermore aphakia mice may be used as a novel model of non-motor symptoms in PD. (C) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:406 / 412
页数:7
相关论文
共 43 条
[1]  
AGID Y, 1986, CLIN NEUROPHARMACOL, V9, pS22, DOI 10.1097/00002826-198600092-00004
[2]   PROCEDURAL MEMORY AND PARKINSONS-DISEASE [J].
ALLAIN, H ;
LIEURY, A ;
QUEMENER, V ;
THOMAS, V ;
REYMANN, JM ;
GANDON, JM .
DEMENTIA, 1995, 6 (03) :174-178
[3]   Cognitive dysfunction and dementia in Parkinson's disease [J].
Bosboom, JLW ;
Stoffers, D ;
Wolters, EC .
JOURNAL OF NEURAL TRANSMISSION, 2004, 111 (10-11) :1303-1315
[4]   Toxin-induced models of Parkinson's disease [J].
Bové J. ;
Prou D. ;
Perier C. ;
Przedborski S. .
NeuroRX, 2005, 2 (3) :484-494
[5]   Neuropsychiatric disturbances in Parkinson's disease clusters in five groups with different prevalence of dementia [J].
Bronnick, K ;
Aarsland, D ;
Larsen, JP .
ACTA PSYCHIATRICA SCANDINAVICA, 2005, 112 (03) :201-207
[6]   Effect of training on motor abilities of heterozygous staggerer mutant (Rora+/Rorasg) mice during aging [J].
Caston, J ;
Hilber, P ;
Chianale, C ;
Mariani, J .
BEHAVIOURAL BRAIN RESEARCH, 2003, 141 (01) :35-42
[7]   Dopaminergic modulation of cognitive function-implications for L-DOPA treatment in Parkinson's disease [J].
Cools, R .
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 2006, 30 (01) :1-23
[8]  
DICHIARA G, 1993, ADV NEUROL, V60, P102
[9]   Chronic 3,4-dihydroxyphenylalanine treatment induces dyskinesia in aphakia mice, a novel genetic model of Parkinson's disease [J].
Ding, Yunmin ;
Restrepo, Jacqueline ;
Won, Lisa ;
Hwang, Dong-Youn ;
Kim, Kwang-Soo ;
Kang, Un Jung .
NEUROBIOLOGY OF DISEASE, 2007, 27 (01) :11-23
[10]   Medical burden and cognition in older patients in primary care: Selective deficits in attention [J].
Duff, Kevin ;
Mold, James W. ;
Roberts, Michelle M. ;
McKay, Sherry L. .
ARCHIVES OF CLINICAL NEUROPSYCHOLOGY, 2007, 22 (05) :569-575